Advaxis
ADXS
$0.56
Share price
4.62%
Change (1 day)
-41.58%
Change (1 year)
Categories
Advaxis (ADXS) - P/B ratio
P/B ratio as of May 2024 : -0.9254
According to Advaxis's latest financial reports the company has a price-to-book ratio of -0.9254.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Advaxis - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.1322 | -93.33% |
| 2022-12-31 | -1.98 | -398.88% |
| 2021-12-31 | 0.6634 | -33.48% |
| 2020-12-31 | 0.9973 | -190.13% |
| 2019-12-31 | -1.11 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | 0.0005 | -100.05% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | 2.65 | -386.51% | 🇺🇸 USA |
 Heska Corporation
HSKA | 3.14 | -438.80% | 🇺🇸 USA |